Diabetes in Developing Countries

Diabetes in developing countries Deaths from diabetes, which has two primary forms including type1 and type2 diabetes, have become a significant problem in the world. Nowadays, diabetes is still a disease not having precise method to cure. As a result of surplus blood sugar, it has a negative effect on the human body and leads to several complications, such as vision problems, kidney damage, nerve damage and heart and circulation problems (Pollock, 2006). Consequently, the increased risk of these diseases makes it become one of the major causes of deaths. For example, according to the WHO (2011), more than 346 million people were diagnosed with it worldwide and between 50% and 80% of them died from CVD. With the development of health care, the mortality in developed countries was decrease, while the situation in developing countries is so serious that 80% of diabetes deaths exist in low and middle income countries (WHO, 2011). For instance, such countries in The Middle East, Pacific Islands and Southeast Asia had 115million diabetic patients in 2000 and the WHO (2011) predicts that the number will double between 2005 and 2030. To mitigate the effects of diabetes, the causes of it need to be detected.
Type 1 diabetes, which is known by lacking insulin production, results from several causes and possible factors. First, genes attribute mainly to it. More than 18 genetic locations related to it have been discovered by researchers and they have found that people with an especially HLA complex which means human leukocyte antigen, are more likely to develop it. A good illustration of it is other autoimmune disorders may caused by such complexes, such as rheumatoid arthritis, ankylosing spondylitis, or juvenile rheumatoid arthritis (Smith, 2010). The second factor is a viral infection which may affects the disease by attacking immune system. For instance, Kamiah (2010) states that a series of diseases from gastrointestinal problems to myocarditis can created by the